Allt inom
Nanexa strengthen the team with professor Axel Glasmacher as medical advisor
Newsletter
Uppsala 24thSeptember 2018
Nanexa strengthen the team with professor Axel Glasmacher as medical advisor
Nanexa has contracated Professor Axel Glasmacher as medical advisor to the drug product project within the cancer indications MDS (Severe myelodysplastic syndrome) and AML (Acute myeloid leukemia).
Nanexa signs collaboration agreement with European animal health company
Pressrelease
Uppsala 1st August 2018
Nanexa signs collaboration agreement with European animal health company
Nanexa has signed a collaboration agreement with the company ViroVet in Belgium to evaluate PharmaShell® together with one of their new drug substances for the treatment of a virus-related disease in cattle.